Raras
Buscar doenças, sintomas, genes...
Síndrome do QT longo de Romano-Ward
ORPHA:101016CID-10 · I45.8CID-11 · BC65.0DOENÇA RARA

Doença cardíaca hereditária caracterizada por prolongamento do intervalo QT no ECG basal e por alto risco de arritmias potencialmente fatais.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença cardíaca hereditária caracterizada por prolongamento do intervalo QT no ECG basal e por alto risco de arritmias potencialmente fatais.

Publicações científicas
199 artigos
Último publicado: 2025 Jun 19
Medicamentos
5 registrados
RANOLAZINE, IVACAFTOR, LUMACAFTOR

Tem tratamento?

5 medicamentos registrados
Ver detalhes, fases e interações →
RANOLAZINEIVACAFTORLUMACAFTORPRINABERELDOFETILIDE

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
40.0
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: I45.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
30 sintomas
😀
Face
16 sintomas
🦴
Ossos e articulações
14 sintomas
🧠
Neurológico
8 sintomas
👂
Ouvidos
7 sintomas
📏
Crescimento
6 sintomas

+ 42 sintomas em outras categorias

Características mais comuns

100%prev.
Intervalo QTc prolongado
55%prev.
Síncope
Frequente (79-30%)
55%prev.
Bradicardia sinusal
Frequente (79-30%)
55%prev.
Onda T anormal
Frequente (79-30%)
17%prev.
Torsades de pointes
Ocasional (29-5%)
17%prev.
Morte cardíaca súbita
Ocasional (29-5%)
141sintomas
Muito frequente (1)
Frequente (3)
Ocasional (6)
Muito raro (3)
Sem dados (128)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 141 características clínicas mais associadas, ordenadas por frequência.

Intervalo QTc prolongadoProlonged QTc interval
Muito frequente100%
SíncopeSyncope
Frequente (79-30%)55%
Bradicardia sinusalSinus bradycardia
Frequente (79-30%)55%
Onda T anormalAbnormal T-wave
Frequente (79-30%)55%
Torsades de pointesTorsade de pointes
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico199PubMed
Últimos 10 anos106publicações
Pico201516 papers
Linha do tempo
2025Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2015Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

21 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

AKAP9A-kinase anchor protein 9Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. Required to maintain the integrity of the Golgi apparatus (PubMed:10202149, PubMed:15047863). Required for microtubule nucleation at the cis-side of the Golgi apparatus (PubMed:15047863, PubMed:19242490). Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase (PubMed:25657325). In complex with PDE4DIP isoform 13/MMG8/SMYLE, recruit

LOCALIZAÇÃO

Golgi apparatusCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (9)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Long QT syndrome 11

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

OUTRAS DOENÇAS (3)
long QT syndrome 11Brugada syndromefamilial long QT syndrome
HGNC:379UniProt:Q99996
ALG10BDol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase BCandidate gene tested inTolerante
FUNÇÃO

Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase that operates in the biosynthetic pathway of dolichol-linked oligosaccharides, the glycan precursors employed in protein asparagine (N)-glycosylation. The assembly of dolichol-linked oligosaccharides begins on the cytosolic side of the endoplasmic reticulum membrane and finishes in its lumen. The sequential addition of sugars to dolichol pyrophosphate produces dolichol-linked oligosaccharides containing fourteen sugars, includi

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
OUTRAS DOENÇAS (1)
long QT syndrome 2
HGNC:HGNC:31088UniProt:Q5I7T1
KCNJ2Inward rectifier potassium channel 2Disease-causing germline mutation(s) inModerado
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:36149965, PubMed:7590287, PubMed:9490857). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:7590287, PubMed:7696590). The inward rectification is mainly due to the blockage of outward current by inter

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (5)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunitsClassical Kir channelsPhase 4 - resting membrane potentialSensory perception of sour taste
MECANISMO DE DOENÇA

Long QT syndrome 7

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
10.1 TPM
Brain Spinal cord cervical c-1
9.1 TPM
Sangue
6.5 TPM
Coração - Ventrículo esquerdo
5.5 TPM
Mama
5.1 TPM
OUTRAS DOENÇAS (5)
short QT syndrome type 3Andersen-Tawil syndromeatrial fibrillation, familial, 9short QT syndrome
HGNC:6263UniProt:P63252
NOS1APCarboxyl-terminal PDZ ligand of neuronal nitric oxide synthase proteinModifying germline mutation inRestrito
FUNÇÃO

Adapter protein involved in neuronal nitric-oxide (NO) synthesis regulation via its association with nNOS/NOS1. The complex formed with NOS1 and synapsins is necessary for specific NO and synapsin functions at a presynaptic level. Mediates an indirect interaction between NOS1 and RASD1 leading to enhance the ability of NOS1 to activate RASD1. Competes with DLG4 for interaction with NOS1, possibly affecting NOS1 activity by regulating the interaction between NOS1 and DLG4 (By similarity). In kidn

LOCALIZAÇÃO

Cell projection, filopodiumCell projection, podosome

MECANISMO DE DOENÇA

Nephrotic syndrome 22

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS22 is an autosomal recessive, steroid-resistant form characterized by onset of progressive kidney dysfunction in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.6 TPM
Cerebelo
20.8 TPM
Brain Frontal Cortex BA9
14.7 TPM
Córtex cerebral
11.6 TPM
Brain Anterior cingulate cortex BA24
9.1 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 22familial long QT syndrome
HGNC:16859UniProt:O75052
CALM2Calmodulin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:26969752, PubMed:27165696). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:26969752, PubMed:27165696, PubMed:35568036). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
CASP4 inflammasome assemblyEnterobacterial factors antagonize host defense
MECANISMO DE DOENÇA

Long QT syndrome 15

A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

OUTRAS DOENÇAS (3)
long QT syndrome 15catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:1445UniProt:P0DP24
ANK2Ankyrin-2Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1

LOCALIZAÇÃO

Cytoplasm, cytoskeletonMembraneCytoplasm, myofibril, sarcomere, M lineApical cell membraneCell membranePostsynaptic cell membraneEarly endosomeRecycling endosomeLysosomeMitochondrionCytoplasm, myofibril, sarcomere, Z lineCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportInteraction between L1 and Ankyrins
MECANISMO DE DOENÇA

Long QT syndrome 4

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 4 shows many atypical features compared to classical long QT syndromes, including pronounced sinus bradycardia, polyphasic T waves and atrial fibrillation. Cardiac repolarization defects may be not as severe as in classical LQT syndromes and prolonged QT interval on EKG is not a consistent feature.

OUTRAS DOENÇAS (2)
cardiac arrhythmia, ankyrin-B-relatedfamilial long QT syndrome
HGNC:493UniProt:Q01484
KCNQ1Potassium voltage-gated channel subfamily KQT member 1Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Pore-forming subunit of the voltage-gated potassium (Kv) channel involved in the regulation of cardiomyocyte excitability and important in normal development and functions of myocardium, inner ear, stomach and colon (PubMed:10646604, PubMed:25441029). Associates with KCNE beta subunits that modulates current kinetics (PubMed:10646604, PubMed:11101505, PubMed:19687231, PubMed:8900283, PubMed:9108097, PubMed:9312006). Induces a voltage-dependent current by rapidly activating and slowly deactivatin

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicle membraneEarly endosomeMembrane raftEndoplasmic reticulumBasolateral cell membraneApical cell membrane

VIAS BIOLÓGICAS (3)
Phase 2 - plateau phasePhase 3 - rapid repolarisationVoltage gated Potassium channels
MECANISMO DE DOENÇA

Long QT syndrome 1

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
207.0 TPM
Estômago
97.9 TPM
Tireoide
84.2 TPM
Pâncreas
31.9 TPM
Rim - Medula
24.6 TPM
OUTRAS DOENÇAS (8)
short QT syndrome type 2Jervell and Lange-Nielsen syndrome 1long QT syndrome 1atrial fibrillation, familial, 3
HGNC:6294UniProt:P51787
SNTA1Alpha-1-syntrophinDisease-causing germline mutation(s) (gain of function) inTolerante
FUNÇÃO

Adapter protein that binds to and probably organizes the subcellular localization of a variety of membrane proteins. May link various receptors to the actin cytoskeleton and the extracellular matrix via the dystrophin glycoprotein complex. Plays an important role in synapse formation and in the organization of UTRN and acetylcholine receptors at the neuromuscular synapse. Binds to phosphatidylinositol 4,5-bisphosphate (By similarity)

LOCALIZAÇÃO

Cell membrane, sarcolemmaCell junctionCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Long QT syndrome 12

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
182.9 TPM
Músculo esquelético
177.8 TPM
Brain Caudate basal ganglia
158.7 TPM
Artéria tibial
152.4 TPM
Brain Putamen basal ganglia
146.0 TPM
OUTRAS DOENÇAS (2)
long QT syndrome 12familial long QT syndrome
HGNC:11167UniProt:Q13424
KCNJ5G protein-activated inward rectifier potassium channel 4Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by external barium. This potassium channel is control

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
MECANISMO DE DOENÇA

Long QT syndrome 13

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
62.9 TPM
Pituitária
25.4 TPM
Baço
10.2 TPM
Pâncreas
8.2 TPM
Rim - Medula
6.3 TPM
OUTRAS DOENÇAS (5)
familial hyperaldosteronism type IIIlong QT syndrome 13familial atrial fibrillationAndersen-Tawil syndrome
HGNC:6266UniProt:P48544
CALM3Calmodulin-3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:31454269). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:31454269, PubMed:35568036). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain kinases and calmodulin-dependent

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
CASP4 inflammasome assemblyEnterobacterial factors antagonize host defense
MECANISMO DE DOENÇA

Ventricular tachycardia, catecholaminergic polymorphic, 6

An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. CPVT6 inheritance is autosomal dominant.

OUTRAS DOENÇAS (3)
long QT syndrome 16catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:1449UniProt:P0DP25
SCN5ASodium channel protein type 5 subunit alphaDisease-causing germline mutation(s) (gain of function) inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membraneCytoplasm, perinuclear regionCell membrane, sarcolemma, T-tubuleCell junction

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Progressive familial heart block 1A

A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
36.1 TPM
Coração - Ventrículo esquerdo
35.1 TPM
Cervix Ectocervix
5.3 TPM
Cervix Endocervix
4.1 TPM
Nervo tibial
2.9 TPM
OUTRAS DOENÇAS (16)
progressive familial heart block, type 1Aventricular fibrillation, paroxysmal familial, type 1sick sinus syndrome 1long QT syndrome 3
HGNC:10593UniProt:Q14524
TBX5T-box transcription factor TBX5Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

DNA-binding protein that regulates the transcription of several genes and is involved in heart development and limb pattern formation (PubMed:25725155, PubMed:25963046, PubMed:26917986, PubMed:27035640, PubMed:29174768, PubMed:8988164). Binds to the core DNA motif of NPPA promoter (PubMed:26926761)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (3)
YAP1- and WWTR1 (TAZ)-stimulated gene expressionPhysiological factorsCardiogenesis
MECANISMO DE DOENÇA

Holt-Oram syndrome

Developmental disorder affecting the heart and upper limbs. It is characterized by thumb anomaly and atrial septal defects.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
71.0 TPM
Pulmão
35.0 TPM
Esôfago - Muscular
20.7 TPM
Esôfago - Junção
15.3 TPM
Coração - Ventrículo esquerdo
14.7 TPM
OUTRAS DOENÇAS (2)
Holt-Oram syndromefamilial long QT syndrome
HGNC:11604UniProt:Q99593
KCNH2Voltage-gated inwardly rectifying potassium channel KCNH2Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel (PubMed:10219239, PubMed:10753933, PubMed:10790218, PubMed:10837251, PubMed:11997281, PubMed:12063277, PubMed:18559421, PubMed:22314138, PubMed:22359612, PubMed:26363003, PubMed:27916661, PubMed:9230439, PubMed:9351446, PubMed:9765245). Channel properties are modulated by cAMP and subunit assembly (PubMed:10837251). Characterized by unusual gating kinetics by producing relatively small outward currents during mem

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationVoltage gated Potassium channels
MECANISMO DE DOENÇA

Long QT syndrome 2

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Deafness is often associated with long QT syndrome type 2.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
85.3 TPM
Cólon sigmoide
75.2 TPM
Cerebelo
71.0 TPM
Cérebro - Hemisfério cerebelar
64.7 TPM
Testículo
62.0 TPM
OUTRAS DOENÇAS (4)
short QT syndrome type 1long QT syndrome 2short QT syndromefamilial long QT syndrome
HGNC:6251UniProt:Q12809
CAV3Caveolin-3Disease-causing germline mutation(s) (gain of function) inTolerante
FUNÇÃO

May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity). Mediates the recruitment of CAVIN2 and CAVIN3 proteins to the caveolae (PubMed:19262564)

LOCALIZAÇÃO

Golgi apparatus membraneCell membraneMembrane, caveolaCell membrane, sarcolemma

VIAS BIOLÓGICAS (1)
Smooth Muscle Contraction
MECANISMO DE DOENÇA

HyperCKmia

Characterized by persistent elevated levels of serum creatine kinase without muscle weakness.

OUTRAS DOENÇAS (7)
rippling muscle disease 2distal myopathy, Tateyama typelong QT syndrome 9creatine phosphokinase, elevated serum
HGNC:1529UniProt:P56539
KCNE2Potassium voltage-gated channel subfamily E member 2Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits (PubMed:10219239, PubMed:11034315, PubMed:11101505, PubMed:12185453, PubMed:20533308). KCNE2 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:10219239, PubMed:11034315, PubMed:11101505, PubMed:12185453, PubMed:20533308). Alters the gating of the

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Long QT syndrome 6

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Estômago
306.8 TPM
Testículo
5.9 TPM
Aorta
2.9 TPM
Nervo tibial
2.6 TPM
Artéria tibial
2.5 TPM
OUTRAS DOENÇAS (4)
long QT syndrome 6atrial fibrillation, familial, 4familial long QT syndromefamilial atrial fibrillation
HGNC:6242UniProt:Q9Y6J6
TRDNTriadinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact (By similarity). Required for normal skeletal muscle strength. Plays a role in excitation-contraction coupling in the heart and in regulating the rate of heart beats

LOCALIZAÇÃO

Cell membraneSarcoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
Ion homeostasisStimuli-sensing channels
MECANISMO DE DOENÇA

Cardiac arrhythmia syndrome, with or without skeletal muscle weakness

An autosomal recessive cardiac disorder characterized by stress-induced arrhythmias in infancy or early childhood. Patients present with recurrent syncope or cardiac arrest after physical activity or emotional stress. Sudden death may occur in early childhood. Some patients have muscle weakness.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
361.9 TPM
Coração - Átrio
55.6 TPM
Coração - Ventrículo esquerdo
40.6 TPM
Fallopian Tube
7.3 TPM
Pituitária
6.6 TPM
OUTRAS DOENÇAS (3)
catecholaminergic polymorphic ventricular tachycardia 5catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:12261UniProt:Q13061
SCN10ASodium channel protein type 10 subunit alphaDisease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Episodic pain syndrome, familial, 2

An autosomal dominant neurologic disorder characterized by adult-onset of paroxysmal pain mainly affecting the distal lower extremities.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.5 TPM
Coração - Átrio
0.1 TPM
Aorta
0.1 TPM
Coração - Ventrículo esquerdo
0.0 TPM
Artéria coronária
0.0 TPM
OUTRAS DOENÇAS (7)
episodic pain syndrome, familial, 2paroxysmal extreme pain disorderfamilial long QT syndromeBrugada syndrome
HGNC:10582UniProt:Q9Y5Y9
KCNE1Potassium voltage-gated channel subfamily E member 1Disease-causing germline mutation(s) (loss of function) inModerado
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE1 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:19219384, PubMed:20533308, PubMed:9230439). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:19219384). Associates with KCNQ1/KVLQT1 alpha subunit

LOCALIZAÇÃO

Cell membraneApical cell membraneMembrane raft

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Jervell and Lange-Nielsen syndrome 2

An autosomal recessive disorder characterized by congenital deafness, prolongation of the QT interval, syncopal attacks due to ventricular arrhythmias, and a high risk of sudden death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Sangue
5.9 TPM
Baço
3.6 TPM
Pulmão
3.4 TPM
Adipose Visceral Omentum
1.0 TPM
Fígado
1.0 TPM
OUTRAS DOENÇAS (5)
Jervell and Lange-Nielsen syndrome 2long QT syndrome 5familial long QT syndromeJervell and Lange-Nielsen syndrome
HGNC:6240UniProt:P15382
CACNA1CVoltage-dependent L-type calcium channel subunit alpha-1CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By sim

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemmaPerikaryonPostsynaptic density membraneCell projection, dendriteCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (5)
NCAM1 interactionsRegulation of insulin secretionAdrenaline,noradrenaline inhibits insulin secretionPhase 0 - rapid depolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Timothy syndrome

Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism.

OUTRAS DOENÇAS (10)
Timothy syndromelong QT syndrome 8Brugada syndrome 3neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
HGNC:1390UniProt:Q13936
CALM1Calmodulin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Among the

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium, flagellum

VIAS BIOLÓGICAS (10)
Cam-PDE 1 activationFCGR3A-mediated IL10 synthesisPKA activationSmooth Muscle ContractionCa2+ pathway
MECANISMO DE DOENÇA

Ventricular tachycardia, catecholaminergic polymorphic, 4

An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. CPVT4 inheritance is autosomal dominant.

OUTRAS DOENÇAS (4)
long QT syndrome 14catecholaminergic polymorphic ventricular tachycardia 4catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:1442UniProt:P0DP23
SCN4BSodium channel regulatory subunit beta-4Disease-causing germline mutation(s) (gain of function) inTolerante
FUNÇÃO

Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Long QT syndrome 10

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
118.2 TPM
Cerebelo
114.0 TPM
Brain Caudate basal ganglia
90.3 TPM
Brain Putamen basal ganglia
72.8 TPM
Brain Frontal Cortex BA9
45.2 TPM
OUTRAS DOENÇAS (3)
long QT syndrome 10familial atrial fibrillationfamilial long QT syndrome
HGNC:10592UniProt:Q8IWT1

Medicamentos e terapias

RANOLAZINEPhase 2

Mecanismo: Sodium channel protein type V alpha subunit blocker

IVACAFTORPhase 2

Mecanismo: Cystic fibrosis transmembrane conductance regulator positive modulator

LUMACAFTORPhase 2

Mecanismo: Cystic fibrosis transmembrane conductance regulator stabiliser

PRINABERELPhase 1

Mecanismo: Estrogen receptor beta agonist

DOFETILIDEPhase 1

Mecanismo: HERG blocker

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

338 variantes patogênicas registradas no ClinVar.

🧬 AKAP9: NM_005751.5(AKAP9):c.571C>T (p.Gln191Ter) ()
🧬 AKAP9: NM_005751.5(AKAP9):c.11098-17C>G ()
🧬 AKAP9: NM_005751.5(AKAP9):c.4148+74T>A ()
🧬 AKAP9: GRCh37/hg19 7q21.2(chr7:91737874-92247201)x1 ()
🧬 AKAP9: GRCh37/hg19 7q11.23-21.3(chr7:74666254-97791584)x1 ()
Ver todas no ClinVar

Vias biológicas (Reactome)

59 vias biológicas associadas aos genes desta condição.

Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Phase 3 - rapid repolarisation Phase 2 - plateau phase Anchoring of the basal body to the plasma membrane Signaling by BRAF and RAF1 fusions AURKA Activation by TPX2 Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein Activation of G protein gated Potassium channels Classical Kir channels Phase 4 - resting membrane potential Sensory perception of sour taste Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits CASP4 inflammasome assembly Enterobacterial factors antagonize host defense Interaction between L1 and Ankyrins COPI-mediated anterograde transport Voltage gated Potassium channels Formation of the dystrophin-glycoprotein complex (DGC) Phase 0 - rapid depolarisation YAP1- and WWTR1 (TAZ)-stimulated gene expression Physiological factors Cardiogenesis Smooth Muscle Contraction Stimuli-sensing channels Ion homeostasis Adrenaline,noradrenaline inhibits insulin secretion NCAM1 interactions Regulation of insulin secretion CaMK IV-mediated phosphorylation of CREB Calmodulin induced events Cam-PDE 1 activation CaM pathway Platelet degranulation Translocation of SLC2A4 (GLUT4) to the plasma membrane Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation PKA activation DARPP-32 events Synthesis of IP3 and IP4 in the cytosol Calcineurin activates NFAT eNOS activation Transcriptional activation of mitochondrial biogenesis Inactivation, recovery and regulation of the phototransduction cascade FCERI mediated Ca+2 mobilization Ca2+ pathway Reduction of cytosolic Ca++ levels Sodium/Calcium exchangers Unblocking of NMDA receptors, glutamate binding and activation CREB1 phosphorylation through the activation of Adenylate Cyclase CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde Ras activation upon Ca2+ influx through NMDA receptor Activation of Ca-permeable Kainate Receptor Uptake and function of anthrax toxins VEGFR2 mediated vascular permeability VEGFR2 mediated cell proliferation Sensory perception of sweet, bitter, and umami (glutamate) taste

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
1Fase 12
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 5 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome do QT longo de Romano-Ward

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

4 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
20 papers (10 anos)
#1

Characterization of an induced pluripotent stem cell line from a long QT syndrome type 1 patient possessing the KCNQ1 c.691C > T (p.Arg231Cys) variant.

Stem cell research2026 Apr

Long QT syndrome type 1 (LQT1), the most prevalent subtype, is attributed to variants in KCNQ1, and is characterized at the cell level by diminished slow delayed rectifier potassium current and disrupted cardiomyocyte repolarization. At the patient level, impaired ventricular repolarization prolongs the QT interval on the electrocardiogram and is associated with life-threatening arrhythmias, often precipitated by physical exertion. Here, an induced pluripotent stem cell line was reprogrammed from an individual carrying the KCNQ1 c.691C > T (p.Arg231Cys) variant with a family history of sudden death; the line demonstrates normal stem cell morphology and karyotype, differentiation capacity, and pluripotency, enabling disease modeling.

#2

Mechano-electrical feedback in transgenic rabbit models of long QT syndrome Type 2 and short QT syndrome Type 1.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026 Feb 03

Electromechanical coupling and mechano-electrical feedback (MEF) are crucial for cardiac function, but their pro-arrhythmic roles in short and long QT syndromes (SQT1 and LQT2) are not fully understood. We aimed to evaluate MEF-induced electrical changes, their arrhythmic impact, and the involvement of stretch-activated channels (SACs) in transgenic rabbit models of SQT1 and LQT2. Patch-clamp and fluorescence imaging were used to analyse action potential duration (APD), Ca²⁺ transients, and contractility in ventricular cardiomyocytes (VCMs) from LQT2, SQT1 and wild-type (WT) rabbits. LQT2 cells showed prolonged APD and Ca²⁺ transients, increased early afterdepolarizations, Ca²⁺ oscillations, and impaired mechanics compared to WT and SQT1. The cellular electromechanical window (Ca²⁺-transient duration minus APD) was more negative in LQT2 and more positive in SQT1 than in WT. QTc prolonged with preload/afterload increase and decreased with preload reduction across all genotypes, but MEF-induced QTc changes and dispersion were most pronounced in LQT2. Ex vivo Langendorff experiments showed that increased right ventricular (RV) pressure prolonged APD and QTc in WT hearts. This was attenuated by the SAC blocker GSMTx4, suggesting a role for SACs in MEF. In silico models of human VCMs including SACs confirmed higher vulnerability to stretch/MEF-induced arrhythmias, including re-entry, in SQT1 and LQT2. Mechano-electrical feedback-induced electrical changes, partly mediated by SACs, occur in WT, SQT1, and LQT2, but MEF effects are strongest in LQT2. Mechano-electrical feedback induces pro-arrhythmic effects in silico more prominently in LQT2 and SQT1 than in WT, highlighting the potential pro-arrhythmic role of MEF in a vulnerable electrophysiological substrate.

#3

AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.

European heart journal2026 Jan 07

Type 1 short QT syndrome (SQT1) is a genetic channelopathy caused by gain-of-function variants in KCNH2, resulting in shortened cardiac repolarization and QT intervals, which predispose patients to ventricular arrhythmias and sudden cardiac death. This study aimed to investigate the therapeutic efficacy of KCNH2-specific suppression-and-replacement (KCNH2-SupRep) gene therapy in a transgenic rabbit model of SQT1. KCNH2-SupRep was developed by combining a KCNH2-shRNA with its corresponding shRNA-immune KCNH2-cDNA into an AAV9 vector, delivered directly into the aortic root (1 × 1010 vg/kg). Therapeutic efficacy was evaluated in vivo by electrocardiogram, ex vivo by optical mapping, and at cellular levels by patch-clamp, calcium imaging, and qPCR in ventricular cardiomyocytes (VCMs). In vivo, KCNH2-SupRep normalized the heart rate-corrected QT interval (QTc) in SQT1 rabbits, without affecting repolarization heterogeneity. Ex vivo, KCNH2-SupRep corrected the action potential duration (APD90) and resolved the increased apicobasal APD90 heterogeneity observed in untreated (UT)-SQT1 hearts, supporting an antiarrhythmic effect, which was further validated by reduced re-entry formation in silico. At cellular levels, KCNH2-SupRep prolonged APD90 in VCMs from SupRep-SQT1 rabbits closer to wildtype levels compared with UT- and sham-SQT1. Additionally, KCNH2-SupRep restored the cellular surrogate of the electro-mechanical window and normalized IKr in nearly 50% of VCMs, in line with a 50%-60% suppression of the mutant KCNH2 transcript. This proof-of-concept study is the first to demonstrate the efficacy of gene therapy for SQT1 in a medium-sized animal model. KCNH2-SupRep gene therapy successfully corrected the pathologic phenotype in vivo, ex vivo, and at cellular levels in transgenic SQT1 rabbits.

#4

[Exertional syncope: A diagnosis of long QT syndrome. A practice-oriented case report on risk stratification and management].

Praxis2026 Feb

We present the case of a 22-year-old medical student who experienced repeated episodes of syncope during physical exertion. Ini-tial investigations, including a neurological assessment and cardiac examinations involving electrocardiograms (ECGs) and Holter monitoring, were normal. During a subsequent volleyball match, however, she suffered cardiac arrest and required resuscitation and defibrillation with an automated external defibrillator (AED). Analysis of the AED recording revealed ventricular fibrillation (VF) and prompted further diagnostic testing. Long QT syndrome (LQTS) was diagnosed based on the clinical presentation, a prolonged QTc interval on the ECG and documented cardiac arrest with VF. Subsequent genetic testing identified a pathogenic variant in the KCNQ1 gene, confirming the diagnosis of type 1 LQTS. The patient was treated with beta blockers, and an implantable cardioverter-defibrillator (ICD) was implanted. This case highlights the diagnostic and prognostic significance of exercise-induced syncope as a high-risk symptom requiring careful cardiological evaluation, even when initial investigations are unremarkable. It emphasises the high didactic value of AED data analysis and illustrates the application of current guidelines in the management of cardiac channelopathies. Belastungssynkope: Diagnose Long-QT-Syndrom. Wir präsentieren den Fall einer 22-jährigen Medizinstudentin, die während körperlicher Anstrengung eine rezidivierende Synkope erlitt. Initiale Abklärungen, einschliesslich neurologischer Beurteilung und kardialer Untersuchungen mit Elektrokardiogramm (EKG) und Holter-Monitoring, wurden als unauffällig beurteilt. Während eines nachfolgenden Volleyballmatches erlitt sie einen Herzstillstand, der eine Reanimation und Defibrillation mit einem automatisierten externen Defibrillator (AED) erforderte. Die Analyse der AED-Aufzeichnung dokumentierte ein Kammerflimmern (VF) und führte zur weiteren Diagnostik. Die Diagnose eines Long-QT-Syndroms (LQTS) wurde aufgrund der klinischen Präsentation, eines verlängerten QTc-Intervalls im EKG und des dokumentierten Herzstillstands mit VF gestellt. Eine nachfolgende genetische Untersuchung identifizierte eine pathogene Variante im KCNQ1-Gen, was die Diagnose eines LQTS Typ 1 bestätigte. Die Patientin wurde mit Betablockern behandelt, und es wurde ihr ein implantierbarer Kardioverter-Defibrillator (ICD) implantiert. Dieser Fall unterstreicht die diagnostische und prognostische Bedeutung der Belastungssynkope als Hochrisikosymptom, das eine sorgfältige kardiologische Abklärung erfordert, selbst wenn erste Untersuchungen unauffällig sind. Er betont den hohen didaktischen Wert der AED-Datenanalyse und illus­triert die Anwendung aktueller Leitlinien im Management von kardialen Kanalopathien. Schlüsselwörter: Belastungssynkope, Long-QT-Syndrom, Kammerflimmern, kardiogenetische Kanalopathie, implantierbarer Kardioverter-­Defibrillator.

#5

Mapping cardiac innervation in the long QT syndrome type 1 transgenic mouse model using whole heart imaging.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology2026

Cardiac innervation plays a crucial role in maintaining heart function. Abnormalities in cardiac innervation can be associated with arrhythmia, ischemic injury, and dysfunction, as documented in heart transplantation reports. There has been a lack of research on heart innervation patterns in congenital hereditary heart disease, including Long QT Syndrome (LQTS), which is a prevalent form of arrhythmia. By considering this gap, we comparatively analyzed global heart innervation patterns and axon fiber prevalence between wild-type (WT) and the Kcnq1A340E/A340E mutation-bearing LQTS Type 1 transgenic mouse models. Hearts from WT and Kcnq1A340E/A340E mice were immunostained with a pan-neuronal marker TUJ1 and imaged using the Lightsheet microscopy. The whole-heart images were processed and binarized to evaluate nerve fiber density, axon fiber diameter, focusing on fibers < 2.5 μm and > 2.5 μm on the dorsal and ventral sides of the heart, as well as branch number, length, and junction numbers. The comparative global innervation analysis of WT and Kcnq1A340E/A340E transgenic mice hearts did not display a statistically significant difference in the TUJ1 immunoreactive nerve fiber density, analyzed by fluorescence intensity prevalence. Interestingly, the nerve fibers < 2.5 μm were detected to have a lower prevalence in Kcnq1A340E/A340E mice compared to WT mice on both dorsal and ventral sides. Furthermore, the branch number, branch length, or junction number of global heart innervation between the experimental groups showed similar quantitative values. Notably, the overlay of innervation patterns within and between WT and Kcnq1A340E/A340E mice hearts revealed a distinct fiber distribution pattern. These findings indicated a unique, fingerprint-like innervation pattern in each heart, independent of the Kcnq1 mutation. Collectively, our data indicated that the nerve fiber diameter distribution in the hearts of Kcnq1A340E/A340E mice is slightly different from that of WT mice, and that there is a unique innervation pattern in each heart, similar to a heartprint, regardless of the mutation. Deciphering the underlying mechanisms behind ion channel mutations and cardiac innervation patterns by analyzing distinct congenital cardiac diseases awaits future investigation.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC96 artigos no totalmostrando 106

2026

Characterization of an induced pluripotent stem cell line from a long QT syndrome type 1 patient possessing the KCNQ1 c.691C > T (p.Arg231Cys) variant.

Stem cell research
2026

[Exertional syncope: A diagnosis of long QT syndrome. A practice-oriented case report on risk stratification and management].

Praxis
2026

Mechano-electrical feedback in transgenic rabbit models of long QT syndrome Type 2 and short QT syndrome Type 1.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2026

Mapping cardiac innervation in the long QT syndrome type 1 transgenic mouse model using whole heart imaging.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
2026

AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.

European heart journal
2025

Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders-Part II.

Diagnostics (Basel, Switzerland)
2025

Postpartum QT Prolongation in a Long QT Syndrome Type 1 Patient.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2025

Integrative analysis of KCNQ1 variants reveals molecular mechanisms of type 1 long QT syndrome pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America
2024

Establishment of two human induced pluripotent stem cell lines from familial long QT syndrome type 1 patients carrying KCNQ1 mutation.

Stem cell research
2024

Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants.

Circulation research
2024

KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.

European heart journal
2024

Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2024

Interactions between KCNQ1 and KCNH2 may modulate the long QT type 1 phenotype.

Cardiovascular research
2024

Clinical characterization of type 1 long QT syndrome caused by C-terminus Kv7.1 variants.

Heart rhythm
2023

Cardiac response to water activities in children with Long QT syndrome type 1.

PloS one
2023

Unlocking the Potential of Left Cardiac Sympathetic Denervation: A Scoping Review of a Promising Approach for Long QT Syndrome.

Cureus
2023

Spatiotemporal repolarization dispersion before and after exercise in patients with long QT syndrome type 1 versus controls: probing into the arrhythmia substrate.

American journal of physiology. Heart and circulatory physiology
2023

Estimating the probability of early afterdepolarizations and predicting arrhythmic risk associated with long QT syndrome type 1 mutations.

Biophysical journal
2023

Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.

Stem cell research
2023

Computational Study on Effect of KCNQ1 P535T Mutation in a Cardiac Ventricular Tissue.

The Journal of membrane biology
2023

Functional Characterization of a Spectrum of Novel Romano-Ward Syndrome KCNQ1 Variants.

International journal of molecular sciences
2023

A novel stop-gain pathogenic variant in the KCNQ1 gene causing long QT syndrome 1.

European journal of medical research
2022

Cardiac Arrest Following Torsades de Pointes Caused by Hypokalemia and Catecholamines in a Patient with Congenital Long QT Syndrome Type 1 After Surgical Aortic Valve Replacement: A Case Report.

The American journal of case reports
2022

Accelerated QT adaptation following atropine-induced heart rate increase in LQT1 patients versus healthy controls: A sign of disturbed hysteresis.

Physiological reports
2022

The Pathological Mechanisms of Hearing Loss Caused by KCNQ1 and KCNQ4 Variants.

Biomedicines
2022

To Modify or Not to Modify: Allele-Specific Effects of 3'UTR-KCNQ1 Single Nucleotide Polymorphisms on Clinical Phenotype in a Long QT 1 Founder Population Segregating a Dominant-Negative Mutation.

Journal of the American Heart Association
2022

Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes.

International journal of molecular sciences
2022

Generation of a human induced pluripotent stem cell line (JSPHi002-A) from a patient with long-QT syndrome type 1 caused by KCNQ1 c.773A > T mutation.

Stem cell research
2022

Sex hormones and repolarization dynamics during the menstrual cycle in women with congenital long QT syndrome.

Heart rhythm
2022

shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele.

International journal of molecular sciences
2021

Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.

Stem cell research
2021

Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.

European heart journal
2021

Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.

Stem cell research
2021

Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.

Stem cell research
2021

Compound Heterozygous KCNQ1 Mutations Causing Recessive Romano-Ward Syndrome: Functional Characterization by Mutant Co-expression.

Frontiers in cardiovascular medicine
2021

Suppression-Replacement KCNQ1 Gene Therapy for Type 1 Long QT Syndrome.

Circulation
2021

Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.

International journal of molecular sciences
2020

Left Cardiac Sympathetic Denervation Monotherapy in Patients With Congenital Long QT Syndrome.

Circulation. Arrhythmia and electrophysiology
2021

QT correction using Bazett's formula remains preferable in long QT syndrome type 1 and 2.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2021

Long QT syndrome type 1 and 2 patients respond differently to arrhythmic triggers: The TriQarr in vivo study.

Heart rhythm
2020

A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane.

European journal of pharmacology
2021

NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.

Cardiovascular research
2019

Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation.

Stem cell research
2019

Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).

Stem cell research
2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.

Stem cell research
2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.

Stem cell research
2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.

Stem cell research
2019

Altered mechano-electrical coupling: An underappreciated factor in sympathetically mediated torsades de pointes in the long QT1 syndrome.

International journal of cardiology
2019

Identification of a Novel KCNQ1 Frameshift Mutation and Review of the Literature among Iranian Long QT Families.

Iranian biomedical journal
2019

Proarrhythmic proclivity of left-stellate ganglion stimulation in a canine model of drug-induced long-QT syndrome type 1.

International journal of cardiology
2018

Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man.

The American journal of case reports
2018

[Analysis of the KCNQ1 gene mutation in 2 families with congenital long QT syndrome type 1 in Xinjiang Uygur Autonomous Region].

Zhonghua xin xue guan bing za zhi
2019

Mutational and phenotypic spectra of KCNE1 deficiency in Jervell and Lange-Nielsen Syndrome and Romano-Ward Syndrome.

Human mutation
2018

Epilepsy in patients with long QT syndrome type 1: A Norwegian family.

Epilepsy &amp; behavior case reports
2019

Cardiac electrical and mechanical alterations - united in the long QT syndrome.

International journal of cardiology
2019

A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel.

Heart rhythm
2018

Functionally Aberrant Mutant KCNQ1 With Intermediate Heterozygous and Homozygous Phenotypes.

The Canadian journal of cardiology
2018

Extensive Diversity of Molecular Mechanisms Underlying the Congenital Long QT Syndrome Type 1.

The Canadian journal of cardiology
2018

They Are Not Monozygotic Twins - Long QT Syndrome Type 1 (LQT1) and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

Circulation journal : official journal of the Japanese Circulation Society
2019

Electro-mechanical (dys-)function in long QT syndrome type 1.

International journal of cardiology
2019

A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.

Heart and vessels
2018

Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1 - Modified Schwartz Score.

Circulation journal : official journal of the Japanese Circulation Society
2018

Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.

Circulation. Arrhythmia and electrophysiology
2018

Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs.

American heart journal
2018

Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.

Heart rhythm
2018

Transient Outward K+ Current (Ito) Underlies the Right Ventricular Initiation of Polymorphic Ventricular Tachycardia in a Transgenic Rabbit Model of Long-QT Syndrome Type 1.

Circulation. Arrhythmia and electrophysiology
2017

T-Wave Morphology Analysis in Congenital Long QT Syndrome Discriminates Patients From Healthy Individuals.

JACC. Clinical electrophysiology
2018

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.

Stem cell research
2018

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.

BMC medical genetics
2018

Novel frameshift mutation in the KCNQ1 gene responsible for Jervell and Lange-Nielsen syndrome.

Iranian journal of basic medical sciences
2018

Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benign.

Heart rhythm
2017

Architectural T-Wave Analysis and Identification of On-Therapy Breakthrough Arrhythmic Risk in Type 1 and Type 2 Long-QT Syndrome.

Circulation. Arrhythmia and electrophysiology
2018

Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Methods in molecular biology (Clifton, N.J.)
2017

Identification and characterization of a novel recessive KCNQ1 mutation associated with Romano-Ward Long-QT syndrome in two Iranian families.

Journal of electrocardiology
2017

Compound heterozygous KCNQ1 mutations (A300T/P535T) in a child with sudden unexplained death: Insights into possible molecular mechanisms based on protein modeling.

Gene
2017

A novel KCNQ1 nonsense variant in the isoform-specific first exon causes both jervell and Lange-Nielsen syndrome 1 and long QT syndrome 1: a case report.

BMC medical genetics
2017

Clinical profile and mutation spectrum of long QT syndrome in Saudi Arabia: The impact of consanguinity.

Heart rhythm
2017

Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects.

Heart rhythm
2017

KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1.

Journal of medical genetics
2017

Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory.

Clinica chimica acta; international journal of clinical chemistry
2017

Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.

Journal of cardiology
2016

Experience with bisoprolol in long-QT1 and long-QT2 syndrome.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
2016

Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?

Circulation. Cardiovascular genetics
2016

Refractory torsade de pointes induced by terlipressin (Glypressin).

International journal of cardiology
2016

KCNQ1 mutations associated with Jervell and Lange-Nielsen syndrome and autosomal recessive Romano-Ward syndrome in India-expanding the spectrum of long QT syndrome type 1.

American journal of medical genetics. Part A
2016

Effect of Left Cardiac Sympathetic Denervation on the Electromechanical Window in Patients with either Type 1 or Type 2 Long QT Syndrome: A Pilot Study.

Congenital heart disease
2016

"QT clock" to improve detection of QT prolongation in long QT syndrome patients.

Heart rhythm
2016

Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.

Heart rhythm
2015

We only find what we look for: fetal heart rate and the diagnosis of long-QT syndrome.

Circulation. Arrhythmia and electrophysiology
2015

A Common Mutation of Long QT Syndrome Type 1 in Japan.

Circulation journal : official journal of the Japanese Circulation Society
2015

Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.

Circulation. Arrhythmia and electrophysiology
2015

Reassuring News for Genetically Tested, Appropriately Treated, Low-Risk LQTS Patients.

Journal of cardiovascular electrophysiology
2015

Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome.

Circulation. Arrhythmia and electrophysiology
2015

Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of IKs and Ca2+ Cycling.

PloS one
2015

Strain Echocardiography and LQTS Subtypes: Mechanical Alterations in an Electrical Disorder.

JACC. Cardiovascular imaging
2015

Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.

JACC. Cardiovascular imaging
2015

Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.

Stem cell research &amp; therapy
2015

Identification of Low-Risk Adult Congenital LQTS Patients.

Journal of cardiovascular electrophysiology
2015

Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel.

Journal of cardiovascular translational research
2015

Asymptomatic 43-year-old man with family history of sudden death.

Heart (British Cardiac Society)
2016

Dual LQT1 and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1, MYH7, MYLK2, and TMEM70 genes in a three-generation Chinese family.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2015

Cellular mechanisms of mutations in Kv7.1: auditory functions in Jervell and Lange-Nielsen syndrome vs. Romano-Ward syndrome.

Frontiers in cellular neuroscience
2015

Physiological variations, environmental factors, and genetic modifications in inherited LQT syndromes.

Journal of the American College of Cardiology
2015

Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1.

Journal of the American College of Cardiology
2014

Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2015

The Long QT Syndrome: A Review and Mortality Analysis.

Journal of insurance medicine (New York, N.Y.)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome do QT longo de Romano-Ward.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome do QT longo de Romano-Ward

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Characterization of an induced pluripotent stem cell line from a long QT syndrome type 1 patient possessing the KCNQ1 c.691C&#xa0;&gt;&#xa0;T (p.Arg231Cys) variant.
    Stem cell research· 2026· PMID 41802374mais citado
  2. Mechano-electrical feedback in transgenic rabbit models of long QT syndrome Type 2 and short QT syndrome Type 1.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology· 2026· PMID 41553502mais citado
  3. AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.
    European heart journal· 2026· PMID 40884219mais citado
  4. [Exertional syncope: A diagnosis of long QT syndrome. A practice-oriented case report on risk stratification and management].
    Praxis· 2026· PMID 41784516mais citado
  5. Mapping cardiac innervation in the long QT syndrome type 1 transgenic mouse model using whole heart imaging.
    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology· 2026· PMID 41338455mais citado
  6. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders-Part II.
    Diagnostics (Basel)· 2025· PMID 40564888recente
  7. Unlocking the Potential of Left Cardiac Sympathetic Denervation: A Scoping Review of a Promising Approach for Long QT Syndrome.
    Cureus· 2023· PMID 38021601recente
  8. Computational Study on Effect of KCNQ1 P535T Mutation in a Cardiac Ventricular Tissue.
    J Membr Biol· 2023· PMID 37166559recente
  9. Functional Characterization of a Spectrum of Novel Romano-Ward Syndrome KCNQ1 Variants.
    Int J Mol Sci· 2023· PMID 36674868recente
  10. The Pathological Mechanisms of Hearing Loss Caused by KCNQ1 and KCNQ4 Variants.
    Biomedicines· 2022· PMID 36140355recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:101016(Orphanet)
  2. MONDO:0019171(MONDO)
  3. GARD:16547(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q724714(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome do QT longo de Romano-Ward
Compêndio · Raras BR

Síndrome do QT longo de Romano-Ward

ORPHA:101016 · MONDO:0019171
Prevalência
1-5 / 10 000
Herança
Autosomal dominant, Autosomal recessive
CID-10
I45.8 · Outros transtornos especificados da condução
CID-11
Medicamentos
5 registrados
Início
All ages
Prevalência
40.0 (Europe)
MedGen
UMLS
C4551647
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades